Cargando…

Progress in research on paclitaxel and tumor immunotherapy

Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linyan, Chen, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567594/
https://www.ncbi.nlm.nih.gov/pubmed/31223315
http://dx.doi.org/10.1186/s11658-019-0164-y
_version_ 1783427111627784192
author Zhu, Linyan
Chen, Liqun
author_facet Zhu, Linyan
Chen, Liqun
author_sort Zhu, Linyan
collection PubMed
description Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway of paclitaxel. With the advancement of biotechnology, improvements in endophytic fungal strains, and the use of recombination techniques and microbial fermentation engineering, the yield of extracted paclitaxel has increased significantly. Recently, paclitaxel has been found to play a large role in tumor immunity, and it has a great potential for use in many cancer treatments.
format Online
Article
Text
id pubmed-6567594
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65675942019-06-20 Progress in research on paclitaxel and tumor immunotherapy Zhu, Linyan Chen, Liqun Cell Mol Biol Lett Review Letter Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway of paclitaxel. With the advancement of biotechnology, improvements in endophytic fungal strains, and the use of recombination techniques and microbial fermentation engineering, the yield of extracted paclitaxel has increased significantly. Recently, paclitaxel has been found to play a large role in tumor immunity, and it has a great potential for use in many cancer treatments. BioMed Central 2019-06-13 /pmc/articles/PMC6567594/ /pubmed/31223315 http://dx.doi.org/10.1186/s11658-019-0164-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Letter
Zhu, Linyan
Chen, Liqun
Progress in research on paclitaxel and tumor immunotherapy
title Progress in research on paclitaxel and tumor immunotherapy
title_full Progress in research on paclitaxel and tumor immunotherapy
title_fullStr Progress in research on paclitaxel and tumor immunotherapy
title_full_unstemmed Progress in research on paclitaxel and tumor immunotherapy
title_short Progress in research on paclitaxel and tumor immunotherapy
title_sort progress in research on paclitaxel and tumor immunotherapy
topic Review Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567594/
https://www.ncbi.nlm.nih.gov/pubmed/31223315
http://dx.doi.org/10.1186/s11658-019-0164-y
work_keys_str_mv AT zhulinyan progressinresearchonpaclitaxelandtumorimmunotherapy
AT chenliqun progressinresearchonpaclitaxelandtumorimmunotherapy